Lobsor Pharmaceuticals is a privately held company based in Uppsala, Sweden founded in 2013. It is a fully owned subsidiary to STADA Sweden AB. The founders of Lobsor had leading executive roles in NeoPharma during the development and commercialization of Duodopa. Based on this experience, and close liaison with leading neurologists and patient organizations describing the medical needs, the Lecigon treatment system has been developed with the aim of increasing quality of life for individuals affected by progressive Parkinson’s disease and suitable for an invasive treatment.